Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay
Abstract
Follistatin (FST) is a monomeric activin-binding and neutralization protein that has at least three isoforms in human tissues and fluids. The full-length FS315 protein has an acidic 26-residue C-terminal tail that is not present in the shortest form, FS288, due to alternative splicing. An intermediate form, FS303, was identified in follicular fluid that is presumably derived by proteolytic processing of this tail domain. Interestingly, the biochemistry of each of these three isoforms is distinct, including their ability to bind to cell surface proteoglycans, an activity that ranks in the order FS288 > FS303 > FS315. This would suggest that the soluble, circulating FST isoform is likely to be FS315, a hypothesis supported by previous determinations that the serum and follicular fluid forms of FST are biochemically distinct. To test this hypothesis, we developed an immunoassay that is specific for full-length FS315. This assay was validated for use with human serum and follicular fluid samples and then used to examine FST in these fluid compartments. Our results indicate that FS315 is indeed the major circulating FST isoform but is undetectable in follicular fluid samples aspirated from normal women or women with polycystic ovary syndrome. These observations confirm the compartmentalization of FST isoforms according to their biochemical properties and biological actions so that the most soluble form is found in the circulation, whereas the forms that bind to cell surface proteoglycans are found in tissue compartments such as the ovarian follicle. They also confirm that the source of FST in human serum is not the ovarian follicle.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FST is present in three main isoforms, FST288, FST303, and FST315, with FST315 being the predominant isoform in circulation.
“FST is present in three main isoforms, FST288, FST303, and FST315, with FST315 being the predominant isoform found in the circulation [185,194,195].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [195]
Cites
Activin-Binding Protein from Rat Ovary Is Follistatin
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., & Sugino, H. (1990) · Science · doi:10.1126/science.2106159 · Cited by 883 · see citing works
Multiple defects and perinatal death in mice deficient in follistatin
Matzuk, M. M., Lu, N., Vogel, H. S., Sellheyer, K., Roop, D. R., & Bradley, A. (1995) · Nature · doi:10.1038/374360a0 · Cited by 584 · see citing works
Ueno, N., LING, N. C., Ying, S. Y., Esch, F. S., Shimasaki, S., & Guillemin, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8282 · Cited by 445 · see citing works
Robertson, D. M., Klein, R., de Vos, F. L., McLachlan, R. I., Wettenhall, R. E. H., Hearn, M. T. W., Burger, H., & de Kretser, D. M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90430-x · Cited by 345 · see citing works
Welt, C. K., Sidis, Y., Keutmann, H. T., & Schneyer, A. L. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700905 · Cited by 324 · see citing works
Self-citationPrimary structure of the human follistatin precursor and its genomic organization
Shimasaki, S., Koga, M., Esch, F., Cooksey, K., Mercado, M., Koba, A., Ueno, N., Ying, S. Y., Ling, N., & Guillemin, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4218 · Cited by 232 · see citing works
Sugino, K., Kurosawa, N., Nakamura, T., Takio, K., Shimasaki, S., LING, N. C., Titani, K., & Sugino, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82296-7 · Cited by 228 · see citing works
Nakamura, T., Sugino, K., Titani, K., & Sugino, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55015-8 · Cited by 166 · see citing works
Human Follistatin-Related Protein: A Structural Homologue of Follistatin with Nuclear Localization
Tortoriello, D. V., Sidis, Y., Holtzman, D. A., Holmes, W. E., & Schneyer, A. L. (2001) · Endocrinology · doi:10.1210/endo.142.8.8319 · Cited by 152 · see citing works
Self-citationRat follistatin: Gonadal and extragonadal expression and evidence for alternative splicing
Michel, U., Albiston, A. L., & Findlay, J. K. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81072-1 · Cited by 150 · see citing works
Characterization of unique binding kinetics of follistatin and activin or inhibin in serum
Schneyer, A. L., Rzucidlo, D. A., Sluss, P. M., & Crowley, W. F. (1994) · Endocrinology · doi:10.1210/endo.135.2.8033815 · Cited by 143 · see citing works
Self-citationSchneyer, A. L., Fujiwara, T., Fox, J. H., Welt, C. K., Adams, J., Lambert-Messerlian, G. M., & Taylor, A. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6767 · Cited by 119 · see citing works
Self-citationKRUMMEN, L. A., Woodruff, T. K., DeGuzman, G. G., Cox, E. T., Baly, D. L., Mann, E. A., Garg, S., Wong, W. L., Cossum, P. A., & Mather, J. P. (1993) · Endocrinology · doi:10.1210/endo.132.1.7678220 · Cited by 118 · see citing works
Evidence for activin A and follistatin involvement in the systemic inflammatory response
Phillips, D. J., Jones, K. L., Scheerlinck, J. Y., Hedger, M. P., & de Kretser, D. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00516-0 · Cited by 108 · see citing works
Alpha 2-macroglobulin is a binding protein of inhibin and activin.
Vaughan, J. M., & Vale, W. (1993) · Endocrinology · doi:10.1210/endo.132.5.7682939 · Cited by 83 · see citing works
Nakamura, M., Matzuk, M. M., Gerstmayer, B., Bosio, A., Lauster, R., Miyachi, Y., Werner, S., & Paus, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0247fje · Cited by 81 · see citing works
Evans, L., Muttukrishna, S., & Groome, N. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560275 · Cited by 77 · see citing works
Schneyer, A. L., Schoen, A., Quigg, A., & Sidis, Y. (2003) · Endocrinology · doi:10.1210/en.2002-0203 · Cited by 71 · see citing works
Self-citationSidis, Y., Tortoriello, D. V., Holmes, W. E., Pan, Y., Keutmann, H. T., & Schneyer, A. L. (2002) · Endocrinology · doi:10.1210/endo.143.5.8805 · Cited by 67 · see citing works
Self-citationMcConnell, D. S., Wang, Q., Sluss, P. M., Bolf, N., Khoury, R. H., Schneyer, A. L., MIDGLEY, A. R., Reame, N. E., Crowley, W. F., & Padmanabhan, V. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4651 · Cited by 65 · see citing works
Self-citationSerum follistatin levels in women: evidence against an endocrine function of ovarian follistatin
Khoury, R. H., Wang, Q. F., Crowley, W. F., Hall, J. E., Schneyer, A. L., Toth, T. L., MIDGLEY, A. R., & Sluss, P. M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714112 · Cited by 63 · see citing works
Self-citationSchneyer, A. L., Hall, H. A., Lambert-Messerlian, G. M., Wang, Q. F., Sluss, P., & Crowley, W. F. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536619 · Cited by 59 · see citing works
Self-citationLocalization of the heparin binding site of follistatin
Inouye, S., LING, N. C., & Shimasaki, S. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90094-m · Cited by 52 · see citing works
Michel, U., Schneider, O., Kirchhof, C., Meisel, S., Av, S., Wiltfang, J., & Rieckmann, P. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895365 · Cited by 49 · see citing works
Activin-binding proteins in human serum and follicular fluid.
Schneyer, A. L., O'Neil, D. A., & Crowley, W. F. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1592877 · Cited by 41 · see citing works
Self-citationQifa, W., Keutmann, H. T., Schneyer, A. L., & Sluss, P. M. (2000) · Endocrinology · doi:10.1210/endo.141.9.7675 · Cited by 40 · see citing works
Self-citationFujiwara, T., Lambert-Messerlian, G. M., Sidis, Y., Leykin, L., Isaacson, K., Toth, T. L., & Schneyer, A. L. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00652-x · Cited by 37 · see citing works
Self-citationDelbaere, A., Sidis, Y., & Schneyer, A. L. (1999) · Endocrinology · doi:10.1210/endo.140.6.6824 · Cited by 31 · see citing works
Self-citationWang, Q. F., Khoury, R. H., Smith, P. C., McConnell, D. S., Padmanahban, V., MIDGLEY, A. R., Schneyer, A. L., Crowley, W. F., & Sluss, P. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.4.8636347 · Cited by 26 · see citing works
Self-citationIsolation of Drosophila Activin and Follistatin cDNAs using novel MACH amplification protocols
Haerry, T. E., & O’Connor, M. B. (2002) · Gene · doi:10.1016/s0378-1119(02)00463-8 · Cited by 17 · see citing works
Follistatin Physiology and Potential Mechanisms of Action in the Human
Schneyer, A. L., Wang, Q. F., Weiss, J., Boepple, P. A., Hall, J. E., Khoury, R. H., Taylor, A. E., Pralong, F. P., Sluss, P., & Crowley, W. F. (1997) · Springer eBooks · doi:10.1007/978-1-4612-1874-6_3 · Cited by 9 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294 · see citing works
Thompson, T. B., Lerch, T. F., Cook, R. W., Woodruff, T. K., & Jardetzky, T. S. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.008 · Cited by 288 · see citing works
The role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 282 · see citing works
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252 · see citing works
The biology of activin: recent advances in structure, regulation and function
Xia, Y. Y., & Schneyer, A. L. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0549 · Cited by 233 · see citing works
Self-citationSidis, Y., Mukherjee, A., Keutmann, H., Delbaere, A., Sadatsuki, M., & Schneyer, A. (2006) · Endocrinology · doi:10.1210/en.2006-0089 · Cited by 211 · see citing works
Self-citationActivin A in Mammalian Physiology
Bloise, E., Ciarmela, P., Cruz, C. D., Luisi, S. V., Petraglia, F., & dos Reis, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00002.2018 · Cited by 196 · see citing works
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194 · see citing works
Inhibin at 90: From Discovery to Clinical Application, a Historical Review
Makanji, Y., Zhu, J., Mishra, R. K., Holmquist, C., Wong, W. P. S., Schwartz, N. B., Mayo, K. E., & Woodruff, T. K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1003 · Cited by 187 · see citing works
Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
Kota, J., Handy, C. R., Haidet, A. M., Montgomery, C. L., Eagle, A., Rodino‐Klapac, L. R., Tucker, D., Shilling, C. J., Therlfall, W. R., Walker, C. M., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000112 · Cited by 166 · see citing works
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding
Cash, J. N., Rejon, C. A., McPherron, A. C., Bernard, D. J., & Thompson, T. B. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.205 · Cited by 159 · see citing works
FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults
Mukherjee, A., Sidis, Y., Mahan, A. L., Raher, M. J., Xia, Y. Y., Rosen, E. D., Bloch, K. D., Thomas, M. K., & Schneyer, A. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607966104 · Cited by 157 · see citing works
Self-citationLoomans-Kropp, H. A., & Andl, C. D. (2014) · Cancers · doi:10.3390/cancers7010070 · Cited by 148 · see citing works
The structural basis of TGF-β, bone morphogenetic protein, and activin ligand binding
Lin, S. J., Lerch, T. F., Cook, R. W., Jardetzky, T. S., & Woodruff, T. K. (2006) · Reproduction · doi:10.1530/rep.1.01072 · Cited by 138 · see citing works
Pituitary actions of ligands of the TGF-β family: activins and inhibins
Bilezikjian, L. M., Blount, A. L., Donaldson, C., & Vale, W. (2006) · Reproduction · doi:10.1530/rep.1.01073 · Cited by 128 · see citing works
Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio
Hansen, J. S., Rutti, S., Arous, C., Clemmesen, J. O., Secher, N. H., Drescher, A., Gonelle-Gispert, C., Halban, P. A., Pedersen, B. K., Weigert, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3668 · Cited by 125 · see citing works
Inactivating hepatic follistatin alleviates hyperglycemia
Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0048-0 · Cited by 104 · see citing works
Myostatin Inhibitors: Panacea or Predicament for Musculoskeletal Disorders?
Suh, J., & Lee, Y. (2020) · Journal of Bone Metabolism · doi:10.11005/jbm.2020.27.3.151 · Cited by 86 · see citing works
Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., & Guzik, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031261 · Cited by 79 · see citing works
“It circulates in three isoforms: Fst288, Fst303 and Fst301 [84,85].”
BackgroundAdvances in research on pharmacotherapy of sarcopenia
Feike, Y., Liu, Z., & Chen, W. (2021) · Aging Medicine · doi:10.1002/agm2.12168 · Cited by 67 · see citing works
Structural and Biophysical Coupling of Heparin and Activin Binding to Follistatin Isoform Functions
Lerch, T. F., Shimasaki, S., Woodruff, T. K., & Jardetzky, T. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700737200 · Cited by 66 · see citing works
Circulating follistatin in relation to energy metabolism
Hansen, J. S., & Plomgaard, P. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.002 · Cited by 62 · see citing works
The Structure of FSTL3·Activin A Complex
Stamler, R., Keutmann, H. T., Sidis, Y., Kattamuri, C., Schneyer, A. L., & Thompson, T. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801266200 · Cited by 63 · see citing works
Self-citationFollistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis
Brown, M. L., Bonomi, L., Ungerleider, N., Zina, J., Kimura, F., Mukherjee, A., Sidis, Y., & Schneyer, A. (2011) · Obesity · doi:10.1038/oby.2011.97 · Cited by 55 · see citing works
Self-citationPearsall, R. S., Davies, M. V., Cannell, M., Li, J., Widrick, J. J., Mulivor, A. W., Wallner, S., Troy, M., Spaits, M. S., Liharska, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47818-w · Cited by 53 · see citing works
Follistatin Regulates Germ Cell Nest Breakdown and Primordial Follicle Formation
Kimura, F., Bonomi, L. M., & Schneyer, A. L. (2010) · Endocrinology · doi:10.1210/en.2010-0950 · Cited by 52 · see citing works
Self-citationHigh serum follistatin levels in women with ovarian endometriosis
Florio, P., Reis, F. M., Torres, P. B., Calonaci, F., Abrao, M. S., Nascimento, L. L., Franchini, M., Cianferoni, L., & Petraglia, F. (2009) · Human Reproduction · doi:10.1093/humrep/dep195 · Cited by 51 · see citing works
Clinical and therapeutic implications of follistatin in solid tumours
SHI, L., RESAUL, J., OWEN, S., YE, L., & JIANG, W. G. (2016) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20005 · Cited by 47 · see citing works
Female Infertility and Disrupted Angiogenesis Are Actions of Specific Follistatin Isoforms
Lin, S.-Y., Craythorn, R. G., O’Connor, A. E., Matzuk, M. M., Girling, J. E., Morrison, J. R., & de Kretser, D. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0529 · Cited by 46 · see citing works
The Follistatin-288 Isoform Alone Is Sufficient for Survival But Not for Normal Fertility in Mice
Kimura, F., Sidis, Y., Bonomi, L. M., Xia, Y. Y., & Schneyer, A. L. (2009) · Endocrinology · doi:10.1210/en.2009-1176 · Cited by 42 · see citing works
Self-citationActivins and Related Proteins in the Establishment of Pregnancy
Florio, P., Gabbanini, M., Borges, L. E., Bonaccorsi, L., Pinzauti, S., dos Reis, F. M., Torres, P. B., Rago, G., Litta, P., & Petraglia, F. (2010) · Reproductive Sciences · doi:10.1177/1933719109353205 · Cited by 38 · see citing works
Follistatin as potential therapeutic target in prostate cancer
Sepporta, M. V., Tumminello, F. M., Flandina, C., Crescimanno, M., Giammanco, M., Guardia, M. L., Majo, D. D., & Leto, G. (2013) · Targeted Oncology · doi:10.1007/s11523-013-0268-7 · Cited by 30 · see citing works
Zabkiewicz, C., Resaul, J., Hargest, R., Jiang, W. G., & Ye, L. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20035 · Cited by 30 · see citing works
Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle
Castonguay, R., Lachey, J. L., Wallner, S., Strand, J., Liharska, K., Watanabe, A. E., Cannell, M., Davies, M. V., Sako, D., Troy, M., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252304 · Cited by 29 · see citing works
Follistatin Effects in Migration, Vascularization, and Osteogenesis in vitro and Bone Repair in vivo
Fahmy‐Garcia, S., Farrell, E., Witte‐Bouma, J., den Berge, I. J. R.-V., Muñoz, M. S., Mumcuoglu, D., Walles, H., Kluijtmans, S. G. J. M., van der Eerden, B. C. J., van Osch, G. J. V. M., et al. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00038 · Cited by 25 · see citing works
Systemic administration of Follistatin288 increases muscle mass and reduces fat accumulation in mice
Gangopadhyay, S. S. (2013) · Scientific Reports · doi:10.1038/srep02441 · Cited by 25 · see citing works
Mosler, S., Relizani, K., Mouisel, É., Amthor, H., & Diel, P. R. (2014) · Physiological Reports · doi:10.1002/phy2.262 · Cited by 24 · see citing works
Gajos-Michniewicz, A., Pawłowska, E., Ochędalski, T., & Piastowska‐Ciesielska, A. W. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-011-0347-8 · Cited by 22 · see citing works
Nicol, B., Yano, A., Jouanno, E., Guérin, A., Fostier, A., & Guiguen, Y. (2013) · Sexual Development · doi:10.1159/000350687 · Cited by 21 · see citing works
Follistatin N terminus differentially regulates muscle size and fat in vivo
Zheng, H., Qiao, C., Tang, R., Li, J., Bulaklak, K., Huang, Z., Zhao, C., Dai, Y. L., Li, J., & Xiao, X. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.135 · Cited by 20 · see citing works
Bone Geometry Is Altered by Follistatin‐Induced Muscle Growth in Young Adult Male Mice
Chan, A. S. M., McGregor, N. E., Poulton, I. J., Hardee, J. P., Cho, H., Martin, T. J., Gregorevic, P., Sims, N. A., & Lynch, G. S. (2021) · JBMR Plus · doi:10.1002/jbm4.10477 · Cited by 19 · see citing works
Hardy, J. T., Buhimschi, I. A., McCarthy, M. E., Zhao, G., Laky, C. A., Shook, L. L., & Buhimschi, C. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4147 · Cited by 17 · see citing works
Fitzgerald, A. M., Benz, C. L., Clark, A. F., & Wordinger, R. J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10292 · Cited by 17 · see citing works
The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs
Chang, F., Fang, R., Wang, M., Zhao, X., Chang, W., Zhang, Z., Li, N., & Meng, Q. (2016) · Transgenic Research · doi:10.1007/s11248-016-9985-x · Cited by 16 · see citing works
Bickel, D., Shah, R., Gesualdi, S. C., & Haerry, T. E. (2007) · Mechanisms of Development · doi:10.1016/j.mod.2007.09.013 · Cited by 16 · see citing works
Bloise, E., Cassali, G. D., Ferreira, M. C. F., Ciarmela, P., Petraglia, F., & dos Reis, F. M. (2010) · Journal of Dairy Science · doi:10.3168/jds.jds.2009-2981 · Cited by 15 · see citing works
Shen, C., Iskenderian, A., Lundberg, D. M., He, T., Palmieri, K. J., Crooker, R., Deng, Q., Traylor, M. J., Gu, S., Rong, H., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.248195 · Cited by 15 · see citing works
Tao, R., Stöhr, O., Wang, C., Qiu, W., Copps, K. D., & White, M. F. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101703 · Cited by 14 · see citing works
Walpurgis, K., Weigand, T., Knoop, A., Thomas, A., Reichel, C., Dellanna, F., & Thevis, M. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2925 · Cited by 14 · see citing works
Too Many Follistatins: Racing Inside and Getting Out of the Cell
Kumar, T. R. (2005) · Endocrinology · doi:10.1210/en.2005-1210 · Cited by 13 · see citing works
Kawagishi, Y., Pankhurst, M. W., Nakatani, Y., & McLennan, I. S. (2017) · Molecular Reproduction and Development · doi:10.1002/mrd.22828 · Cited by 11 · see citing works
The Role of TGF-β, Activin and Follistatin in Inflammatory Bowel Disease
Esfahani, N. H., & Day, A. S. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord5020015 · Cited by 10 · see citing works
Detection of black market follistatin 344
Reichel, C., Gmeiner, G., & Thevis, M. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2741 · Cited by 9 · see citing works
Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia
Faraoni, E. Y., Abeledo-Machado, A., Pérez, P. A., López, C. A. M., Camilletti, M. A., Peña‐Zanoni, M., Rulli, S. B., Gutiérrez, S., & Dı́az-Torga, G. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0326 · Cited by 8 · see citing works
Utriainen, P., Liu, J., Kuulasmaa, T., & Voutilainen, R. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06392 · Cited by 8 · see citing works
Production of bioactive chicken (Gallus gallus) follistatin-type proteins in E. coli
Lee, S. B., Park, S., & Kim, Y. (2015) · AMB Express · doi:10.1186/s13568-015-0142-3 · Cited by 8 · see citing works
The Reign of Follistatin in Tumors and Their Microenvironment: Implications for Drug Resistance
Sosa, J., Oyelakin, A., & Sinha, S. (2024) · Biology · doi:10.3390/biology13020130 · Cited by 7 · see citing works
Fructose and follistatin potentiate acute MASLD during complete hepatic insulin resistance
Tao, R., Stöhr, O., Tok, O., Andrés-Hernando, A., Qiu, W., He, B., Wang, C., Grøntved, L., Burant, C., Hui, S. T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66296-5 · Cited by 6 · see citing works
Brown, M., Lopez, A., Meyer, N., Richter, A., & Thompson, T. B. (2021) · Endocrinology · doi:10.1210/endocr/bqab019 · Cited by 6 · see citing works
Ongaro, L., & Bernard, D. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf233 · Cited by 5 · see citing works
Khan, M. H., Fatima, M., Adnan, A. B., Jawaid, A., Hassan, S. M., Talal, M., Rahim, S., Mughal, Z. U. N., Patel, A. O., & Singh, A. K. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003584 · Cited by 6 · see citing works
Inhibin, Activin, and Follistatin in Ovarian Physiology
Welt, C. K., & Schneyer, A. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00006-6 · Cited by 5 · see citing works
Self-citationWong, K., Cheung, H. W., Choi, Y., To, N. S., Wan, T. S. M., & Ho, E. N. M. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3540 · Cited by 4 · see citing works
Circulating plasma follistatin follows a 24-hour rhythm in healthy young males
Zilstorff, D. B., Sennels, H. P., Jørgensen, H. L., Albrechtsen, N. J. W., & Richter, M. M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag121 · Cited by 1 · see citing works
Dağ, U., Çağlayan, M., Öncül, H., & Alakuş, M. F. (2020) · International Ophthalmology · doi:10.1007/s10792-020-01501-6 · Cited by 2 · see citing works
Maaeni, Y. M. A., Lee, S. B., Choi, D. H., Mozdziak, P. E., & Kim, Y. (2017) · International Journal of Poultry Science · doi:10.3923/ijps.2018.8.21 · Cited by 1 · see citing works
Folistatina, resistencia a la insulina y composición corporal en adultos colombianos
Toloza, F. J. K., Ricardo-Silgado, M. L., Mantilla-Rivas, J. O., Morales-Álvarez, M. C., Pérez-Matos, M. C., Pinzón-Cortés, J. A., Pérez-Mayorga, M., & Mendivil, C. O. (2018) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.5.1.336 · Cited by 1 · see citing works
CANDIDATE GENES ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME IN ASIAN POPULATIONS: A RESEARCH REVIEW
Vg, A. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2016.v9i5.12432 · Cited by 1 · see citing works
Resaul, J. (2018) · ORCA Online Research @Cardiff (Cardiff University)
Hassan, F., Aftab, S., Rehman, M. S.-U., Arif, S., Safdar, M., Ahmed, S., Ahmad, K., Cerbo, A. D., Azzam, M. M., & Alagawany, M. M. (2025) · Brazilian Journal of Poultry Science · doi:10.1590/1806-9061-2024-2004
- Authors
- Schneyer, A. L., Wang, Q., Sidis, Y., & Sluss, P. M.
- Affiliations
- Massachusetts General Hospital (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-10
- Volume
- 89
- Issue
- 10
- Pages
- 5067-5075
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2082588401
- Cited by
- 71
- References
- 31
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 2
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bayer Corporation
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK055838, DK55838)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD29364, R01HD029364)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- follistatin, alternative splicing, C-terminal tail, immunoassay, follicular fluid, serum, polycystic ovary syndrome, activin-binding protein, proteoglycan binding, ovarian follicles
- MeSH terms
- Antibodies, Monoclonal, Antibody Specificity, Calibration, Cell Line, Female, Humans, Immunoassay, Isomerism, Polycystic Ovary Syndrome, Reproducibility of Results, Follicular Fluid, Follistatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review